The fatality rate can reach 30%, and 30% to 50% of survivors may continue to suffer definitive neurological or psychiatric sequelae [2]. There are no licensed anti-JE drugs available, and the management of patients remains symptomatic. Viruses 2019, 11, 949; doi:10.3390/v11100949 www.mdpi...